May 18, 2020 Enzychem Lifesciences Appoints Duke Medical Coronavirus Task Force Expert Dr. Cameron Wolfe to Lead Development of EC-18 as a COVID-19 Therapeutic Drug | BioSpace Explore further
May 18, 2020 ENZYCHEM LIFESCIENCES APPOINTS DUKE MEDICAL CORONAVIRUS TASK FORCE EXPERT DR. CAMERON WOLFE TO LEAD DEVELOPMENT OF EC-18 AS A COVID-19 THERAPEUTIC DRUG Explore further
May 14, 2020 ENZYCHEM LIFESCIENCES INITIATES PHASE 2 STUDY FOR EC-18 IN PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) DUE TO NOVEL CORONAVIRUS PNEUMONIA Explore further
